Comparative Analysis of Five Highly Conserved Target Sites Within the HIV-1 RNA for Their Susceptibility to Hammerhead Ribozyme-Mediated CleavageIn VitroandIn Vivo-Reference-Cited by-同舟云学术

Comparative Analysis of Five Highly Conserved Target Sites Within the HIV-1 RNA for Their Susceptibility to Hammerhead Ribozyme-Mediated CleavageIn VitroandIn Vivo

Published:1996-01 Issue:3 Volume:6 Page:229-235
ISSN:1087-2906
Container-title:Antisense and Nucleic Acid Drug Development
language:en
Short-container-title:Antisense and Nucleic Acid Drug Development

Author:

RAMEZANI ALI,JOSHI SADHNA

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology,Genetics

Link

http://www.liebertpub.com/doi/pdf/10.1089/oli.1.1996.6.229

Reference33 articles.

1. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

2. Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication—potential effectiveness against most presently sequenced HIV-1 isolates

3. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction

4. Inhibition of HIV-1 Multiplication in a Human CD4+Lymphocytic Cell Line Expressing Antisense and Sense RNA Molecules Containing HIV-1 Packaging Signal and Rev Response Element(s)

5. Inhibition of HIV-1 replication by ribozymes that show poor activityin vitro

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins;Molecular Therapy - Nucleic Acids;2018-12

2. Control of HIV Infection In Vivo Using Gene Therapy with a Secreted Entry Inhibitor;Molecular Therapy - Nucleic Acids;2017-12

3. HIV and Ribozymes;Advances in Experimental Medicine and Biology;2015

4. A novel gene therapy strategy using secreted multifunctional anti-HIV proteins to confer protection to gene-modified and unmodified target cells;Gene Therapy;2013-12-05

5. HIV-1 Gene Therapy at Pre-Integration and Provirus DNA Levels;Current Gene Therapy;2009-02-01